section
cardiopulmonari
system
chapter
next
describ
clinic
featur
felin
cardiomyopathi
therapi
relat
complic
follow
consider
canin
dcm
arrhythmogen
cardiomyopathi
overview
pathophysiolog
felin
hcm
felin
idiopath
hcm
character
hypertrophi
thicken
left
ventricl
unexplain
congenit
heart
diseas
system
hypertens
endocrinopathi
condit
genet
number
felin
breed
includ
main
coon
cat
persian
cat
ragdol
thu
far
one
sarcomer
mutat
identifi
left
right
ventricl
capabl
undergo
signific
morpholog
chang
respons
stress
stimuli
reaction
increas
volum
pressur
work
frequent
lead
chamber
dilat
hypertrophi
along
alter
cytoskelet
matrix
ventricl
myocardi
chamber
respons
develop
chronic
valvular
heart
diseas
cardiac
shunt
system
pulmonari
hypertens
thyrotoxicosi
chronic
anemia
respons
stress
direct
variou
neural
hormon
genet
messag
act
myocardium
signal
influenc
genet
express
cardiomyocyt
interstiti
cell
remodel
ventricl
cardiomyopathi
refer
diseas
myocardium
extens
cardiomyocyt
support
collagen
interstiti
matrix
idiopath
primari
cardiomyopathi
explain
malform
acquir
cardiac
lesion
dysrhythmia
coronari
arteri
diseas
mani
idiopath
cardiomyopathi
genet
diseas
expans
definit
cardiomyopathi
accept
myocardi
diseas
explain
disord
case
term
secondari
cardiomyopathi
use
myocardi
failur
develop
chronic
volum
pressur
overload
ventricl
term
cardiomyopathi
overload
propos
explain
remodel
associ
increas
ventricular
work
although
mani
known
caus
cardiomyopathi
case
cat
dog
idiopath
thought
repres
genet
disord
particularli
true
dilat
cardiomyopathi
dog
hypertroph
cardiomyopathi
cat
stimul
genet
factor
caus
heart
muscl
diseas
poorli
understood
case
cardiomyopathi
irrevers
progress
special
exampl
demonstr
cardiomyopath
state
postpon
arrest
even
revers
exampl
chronic
tachyarrhythmia
caus
cardiomyopathi
loss
myocardi
contractil
revers
arrhythmia
resolv
taurin
defici
cat
classic
exampl
revers
dilat
cardiomyopathi
regress
left
ventricular
hypertrophi
may
occur
success
treatment
system
hypertens
hyperthyroid
cardiomyopathi
often
classifi
postmortem
anatom
appear
left
right
ventricl
correl
echocardiograph
featur
ventricular
anatomi
function
import
form
cardiomyopathi
classifi
follow
see
tabl
myocarditisan
inflamm
heart
muscl
observ
often
cat
may
respons
prematur
ventricular
complex
sudden
death
progress
heart
failur
dilat
cardiomyopathi
dcm
dilat
poorli
contract
left
ventricl
lv
usual
associ
develop
congest
heart
failur
chf
cardiac
arrhythmia
sudden
death
dcm
common
diseas
dog
uncommon
cat
hypertroph
cardiomyopathi
hcm
thicken
lv
wall
unknown
genet
caus
display
consider
phenotyp
heterogen
hcm
mainli
disord
cat
often
lead
cardiac
murmur
chf
thromboembol
diseas
restrict
cardiomyopathi
rcm
heterogen
poorli
character
disord
defin
extens
fibrosi
lv
encount
mainli
matur
older
cat
recogn
caus
arrhythmia
chf
arteri
thromboembol
right
ventricular
cardiomyopathya
disord
affect
mainli
initi
right
ventricl
result
either
chf
ventricular
arrhythmia
unclassifi
cardiomyopathyprimari
lv
diseas
easili
classifi
hcm
dcm
rcm
case
probabl
relat
myocardi
infarct
cardiotoxicityth
heart
also
damag
number
cardiotoxin
list
tabl
outcom
cardiotox
often
arrhythmia
conduct
disturb
sudden
death
develop
secondari
dilat
cardiomyopathi
pattern
ventricular
hypertrophi
diseas
variabl
demonstr
necropsi
echocardiographi
symmetr
concentr
hypertrophi
lv
wall
papillari
muscl
consid
typic
felin
hcm
substanti
variat
locat
sever
hypertrophi
diseas
main
histolog
find
myocardi
cell
hypertrophi
fiber
disarray
small
intramur
coronari
arteri
often
narrow
microscop
fibrosi
myocyt
focal
area
infarct
inflamm
may
observ
left
atrium
la
usual
dilat
wall
may
hypertrophi
increas
pressur
need
fill
lv
atrial
auricular
clot
found
attach
chamber
wall
case
natur
histori
untreat
felin
hcm
quit
variabl
follow
benign
lethal
cours
brief
protract
clinic
diseas
sometim
remark
recoveri
lifethreaten
complic
cat
remain
asymptomat
mani
year
succumb
ever
diseas
clinic
sign
hcm
explain
leftsid
chf
complic
arteri
thromboembol
ate
lv
outflow
tract
obstruct
arrhythmia
capabl
caus
syncop
sudden
cardiac
death
differenti
diagnosi
clinic
sign
hcm
cat
extens
tabl
sodium
iodid
catecholamin
includ
brainheart
syndrom
pheochromocytoma
doxorubicin
digitali
purpurea
foxglov
strophanthu
spp
toad
bufo
toxic
chocol
toxic
primari
idiopath
secondari
caus
cardiomyopathi
consid
import
type
also
see
infect
noninfect
myocard
dcm
develop
secondari
sever
inflammatori
diseas
includ
congenit
heart
diseas
myocard
form
primari
cardiomyopathi
rcm
dcm
echocardiogram
demonstr
thicken
lv
specif
disord
caus
lv
hypertrophi
must
exclud
includ
mitral
valv
malform
caus
dynam
obstruct
lv
outflow
tract
secondari
hypertrophi
congenit
aortic
subaort
stenosi
hyperthyroid
heart
diseas
thyrotoxicosi
hypertens
heart
diseas
focal
basilar
septal
hypertrophi
associ
aortic
dilat
aortoannular
ectasia
acromegali
growth
hormon
excess
pathophysiolog
felin
hcm
figur
relev
diagnosi
drug
therapi
diseas
presumpt
caus
chf
ventricular
diastol
dysfunct
cat
hcm
normal
hyperdynam
lv
eject
fraction
diastol
dysfunct
inabl
fill
left
ventricl
normal
la
pressur
earli
diastol
dysfunct
character
abnorm
myocardi
relax
vigor
la
contract
support
late
diastol
fill
situat
associ
atrial
gallop
often
detect
cat
progress
ventricular
diseas
associ
reduc
chamber
complianc
loss
passiv
lv
ventricular
distens
tissu
injuri
fibrosi
increas
myocardi
chamber
stiff
requir
elev
la
fill
pressur
creat
situat
rapid
earli
diastol
fill
becom
restrict
stiff
ventricl
distend
correl
ventricular
summat
gallop
left
atrium
distend
loss
atrial
contractil
may
develop
reduc
fill
effect
also
predispos
stagnant
flow
format
atrial
thrombi
atrial
fibril
role
myocardi
ischemia
infarct
neurohormon
activ
pathogenesi
progress
tissu
injuri
cardiac
dysfunct
possibl
therapeut
target
bblocker
angiotensin
system
inhibitor
blunt
detriment
respons
demand
ischemiath
sudden
increas
myocardi
oxygen
demand
outstrip
coronari
blood
supplymay
contribut
sudden
develop
leftsid
chf
flash
pulmonari
edema
often
observ
stress
cat
hcm
ischemia
impair
myocardi
fill
contract
reason
drug
antiischem
effect
atenolol
diltiazem
often
prescrib
diseas
systol
abnorm
identifi
cat
hcm
includ
subtl
abnorm
detect
tissu
doppler
echocardiographi
identif
apic
free
wallinfarct
region
wall
motion
abnorm
rare
global
loss
lv
systol
function
dynam
labil
pressur
gradient
lv
aorta
often
identifi
eject
across
lv
outflow
tract
case
systol
gradient
stem
either
septal
papillari
muscl
hypertrophi
midventricular
obstruct
systol
anterior
motion
sam
mitral
valv
caus
mitral
septal
contact
abnorm
document
highqual
echocardiograph
studi
presenc
signific
sam
invari
associ
eccentr
jet
mitral
regurgit
mr
readili
seen
color
doppler
examin
chronic
case
hcm
appear
evolv
restrict
form
cardiomyopathi
either
region
wall
dysfunct
suggest
myocardi
infarct
global
reduc
lv
systol
function
suggest
fibrosi
ischemia
rare
cat
progress
grossli
dilat
form
diseas
clinic
present
examin
find
felin
hcm
variabl
male
cat
predispos
report
cat
age
includ
young
cat
may
affect
previous
note
certain
breed
genet
risk
diseas
uncommon
examin
affect
cat
relat
often
idea
hcm
prompt
auscult
murmur
gallop
sound
cat
sign
heart
diseas
nonspecif
sign
lethargi
anorexia
may
report
key
point
cat
hcm
healthi
asymptomat
diseas
symptomat
leftsid
chf
cat
demonstr
tachypnea
dyspnea
sign
attribut
pulmonari
edema
pleural
effus
cough
occur
inconsist
sign
stress
fever
moderatetosever
anemia
thyrotoxicosi
anesthesia
surgic
procedur
trauma
fluid
therapi
may
precipit
chf
previous
stabl
cat
prior
therapi
corticosteroid
may
anoth
risk
factor
though
caus
effect
firmli
establish
urgent
present
may
follow
ate
termin
aorta
forelimb
cerebrum
syncop
sudden
cardiac
death
occur
less
common
human
diseas
sudden
death
may
explain
coronari
embolu
ventricular
arrhythmia
sign
chf
unrecogn
cat
succumb
hypoxia
typic
physic
examin
featur
hcm
includ
variou
combin
follow
gallop
rhythmthi
relat
ventricular
diastol
dysfunct
heart
failur
systol
murmurmurmur
commonli
due
mr
dynam
lv
outflow
obstruct
murmur
vari
often
increas
intens
higher
heart
rate
higher
sympathet
tone
find
specif
function
eject
murmur
also
becom
intens
increas
sympathet
drive
function
abp
usual
normal
cat
hcm
howev
cat
demonstr
profound
hypotens
associ
cardiogen
shock
along
hypothermia
bradycardia
low
abp
also
may
detect
cat
receiv
diuret
acei
therapi
chf
system
hypertens
may
caus
secondari
lv
hypertrophi
hcm
caus
system
hypertens
number
routin
diagnost
test
help
recogn
stage
hcm
electrocardiogram
may
abnorm
result
inconsist
increas
amplitud
rwave
lead
ii
exceed
mv
left
axi
deviat
compat
concentr
hypertrophi
left
anterior
fascicular
block
may
observ
key
point
normal
ecg
exclud
diagnosi
cardiomyopathi
thorac
radiograph
normal
moder
sever
diseas
demonstr
abnorm
cardiomegali
elong
apex
shift
right
left
la
enlarg
evid
auricular
bulg
dv
view
common
find
cat
chf
cardiac
silhouett
may
enlarg
small
moder
pericardi
effus
caus
chf
cardiac
silhouett
size
may
reduc
consider
diuret
therapi
promin
pulmonari
vascular
pattern
may
indic
pulmonari
hypertens
secondari
elev
lv
diastol
pressur
fluid
retent
increas
lung
densiti
compat
pulmonari
edema
may
focal
patchi
diffus
often
depend
area
typic
dog
chf
pleural
effus
common
acut
chf
chronic
longstand
case
heart
failur
evalu
effus
typic
reveal
modifi
transud
sometim
chylothorax
routin
cbc
clinic
chemistri
unremark
case
unless
thromboembol
intercurr
diseas
creatin
kinas
ck
ast
alt
deriv
skelet
muscl
origin
markedli
elev
thromboembol
limb
renal
function
may
becom
impair
cat
concurr
renal
diseas
treat
heart
failur
diuret
acei
mani
case
advanc
treat
chf
mild
moder
azotemia
serum
thyroxin
normal
cat
idiopath
hcm
unless
manifest
two
diseas
number
recent
report
indic
potenti
valu
measur
serum
plasma
cardiac
troponini
ctni
sinc
protein
increas
cat
hcm
may
becom
use
screen
test
identifi
cat
hcm
key
point
larg
percentag
cat
systol
murmur
echocardiographi
demonstr
normal
heart
trivial
cardiac
patholog
heart
murmur
case
consid
function
like
relat
sympathet
stimul
heart
echocardiographi
definit
diagnosi
stage
hcm
reli
echocardiographi
doppler
studi
interpret
light
clinic
find
typic
hcm
character
echocardiograph
papillari
muscl
thicken
gener
thicken
lv
wall
gener
mm
diastol
normal
decreas
intralumin
size
normal
increas
systol
shorten
fraction
mark
heterogen
pattern
hypertrophi
wall
segment
may
involv
may
gener
involv
greater
involv
septal
free
wall
segment
cat
demonstr
markedli
asymmetr
hypertrophi
mainli
affect
lv
free
wall
find
usual
portend
develop
chf
convers
focal
midventricular
hypertrophi
even
midventricular
obstruct
usual
benign
older
cat
isol
focal
dorsal
septal
hypertrophi
common
find
whether
repres
true
hcm
growth
respons
aortic
dilat
alter
subaort
blood
flow
uncertain
condit
gener
benign
increas
left
atrial
size
strong
indic
risk
ate
chf
doppler
studi
may
demonstr
mr
dynam
obstruct
abnorm
lv
fill
pattern
earli
diastol
dysfunct
character
abnorm
myocardi
relax
shown
doppler
studi
delay
lv
relax
earli
diastol
vigor
la
contract
support
late
diastol
fill
progress
ventricular
diseas
associ
reduc
chamber
complianc
doppler
studi
often
show
promin
earli
fill
e
wave
trivial
atrial
contract
wave
find
gener
preced
develop
chf
differenti
diagnosi
felin
cardiomyopathi
extens
tabl
includ
cardiovascular
noncardiac
disord
felin
rcm
repres
heterogen
disord
latitud
use
place
cat
within
categori
disord
describ
might
interpret
other
intermedi
cardiomyopathi
unclassifi
cardiomyopathi
overview
pathophysiolog
felin
rcm
key
patholog
featur
diffus
multifoc
endomyocardi
myocardi
fibrosi
pathogenesi
lesion
undetermin
anteced
myocard
seem
like
though
unproven
initi
caus
cat
rcm
clearli
repres
late
stage
hcm
complic
myocardi
fibrosi
myocardi
infarct
varieti
necropsi
lesion
observ
cat
demonstr
clinic
featur
rcm
lv
endomyocardi
fibrosi
may
patchi
multifoc
diffus
distribut
left
ventricl
exhibit
region
hypertrophi
overal
wall
thicken
often
region
thin
infarct
lv
free
wall
apex
interspers
focal
hypertrophi
promin
papillari
muscl
hypertrophi
fibrosi
evid
cat
lv
caviti
may
dilat
usual
normal
reduc
size
extrem
endocardi
fibrot
scar
involv
mitral
valv
apparatu
lead
midventricular
stenosi
obliter
lv
apex
common
featur
rcm
strike
biatrial
dilat
system
thromboemboli
common
la
ventricular
mural
thrombi
may
observ
histolog
lesion
includ
endocardi
thicken
endomyocardi
fibrosi
myocardi
interstiti
fibrosi
myocyt
hypertrophi
focal
myocytolysi
necrosi
arteriosclerosi
intramur
coronari
arteri
may
recogn
pathophysiolog
rcm
cat
unresolv
mani
way
fit
intermedi
label
initi
suggest
harpster
figur
echocardiographi
gener
demonstr
mild
systol
dysfunct
region
lv
wall
dysfunct
mild
mitral
tricuspid
valvular
regurgit
elev
la
pressur
impair
lv
distens
restrict
fill
pattern
tall
abbrevi
ewav
small
awav
myocardi
endomyocardi
fibrosi
like
explan
abnorm
progress
increas
la
pressur
develop
combin
ventricular
dysfunct
atrial
stiff
renal
retent
sodium
elev
pulmonari
venou
pressur
predispos
chf
pulmonari
hypertens
pulmonari
edema
pleural
effus
jugular
venou
distent
hepat
congest
typic
manifest
chf
diseas
clinic
diagnosi
biventricular
chf
often
made
stasi
blood
stretch
la
place
affect
cat
risk
atrial
thrombi
system
thromboembol
clinic
find
diagnost
studi
rcm
mani
way
similar
hcm
notabl
differ
cat
rcm
middl
age
older
present
sign
chf
ate
previous
diagnos
hcm
consist
physic
auscultatori
find
loud
gallop
sound
murmur
variabl
less
common
hcm
prematur
ventricular
atrial
beat
common
lead
irregular
rhythm
arteri
puls
sign
elev
system
venou
pressur
includ
hepatomegali
pleural
effus
elev
jugular
venou
pressur
common
may
indic
rv
dysfunct
rv
involv
pulmonari
hypertens
simpli
gener
respons
fluid
retent
compens
chronic
left
heart
failur
electrocardiogram
frequent
abnorm
show
cardiomegali
pattern
axi
deviat
conduct
disturb
along
atrial
ventricular
ectopi
thorac
radiographi
often
impress
character
la
dilat
cardiac
elong
typic
lv
enlarg
cardiac
apex
point
round
cat
manifest
astound
biatrial
enlarg
pericardi
effus
may
enhanc
cardiac
silhouett
size
pleural
effus
typic
echocardiographi
demonstr
number
possibl
abnorm
characterist
featur
rcm
view
echocardiographi
mark
la
biatrial
dilat
mildli
reduc
shorten
fraction
irregular
hyperecho
ventricular
wall
band
span
lv
often
mark
wall
thin
typic
myocardi
infarct
infarct
sever
myocardi
fibrosi
often
creat
segment
hypocontractil
wall
clinic
laboratori
test
cat
rcm
specif
abnorm
attribut
chf
diuret
therapi
thromboembol
describ
hcm
plasma
whole
blood
taurin
measur
cat
decreas
lv
eject
fraction
analysi
pleural
effus
indic
transud
modifi
transud
chyle
predomin
cell
present
macrophag
mesotheli
cell
small
lymphocyt
unless
chylothorax
case
wellpreserv
neutrophil
may
numer
respons
irrit
shown
pion
colleagu
dietari
defici
taurin
account
vast
major
felin
case
dilat
cardiomyopathi
today
dcm
cat
rel
rare
occurr
requir
echocardiograph
evalu
diagnosi
taurin
defici
may
still
observ
cat
eat
mostli
custom
diet
dog
food
case
dcm
idiopath
consequ
myocard
primari
postmortem
lesion
primari
dcm
leftsid
fourchamb
dilat
accompani
necropsi
find
chf
demonstr
congenit
coronari
valvular
heart
diseas
histolog
find
includ
myocyt
loss
promin
interstiti
fibrosi
variabl
degre
hypertrophi
myocytolysi
inflamm
typic
minim
leftsid
biventricular
chf
often
complic
system
thromboembol
typic
consequ
disord
condit
readili
identifi
care
clinic
examin
result
thorac
radiographi
certain
breed
histor
risk
dcm
notabl
burmes
cat
classic
physic
examin
featur
dcm
includ
soft
heart
sound
reduc
contractil
pleural
effus
gallop
rhythm
without
systol
murmur
hypokinet
arteri
puls
dull
left
apic
impuls
clinic
sign
profound
chf
except
case
seen
prior
onset
chf
cat
dcm
like
present
cardiogen
shock
sinu
junction
bradycardia
mark
hypothermia
sever
hypotens
systol
abp
ophthalm
examin
may
indic
hyperreflect
lesion
retin
degener
adjac
optic
disk
caus
taurin
defici
principl
function
disturb
dcm
shown
echocardiographi
mark
reduct
myocardi
contractil
measur
shorten
eject
fraction
morpholog
dilat
thinwal
hypokinet
left
ventricl
observ
often
dilat
cardiac
chamber
ventricular
fill
also
impair
relat
abnorm
relax
muscl
pronounc
cardiac
dilat
reduc
diastol
complianc
often
mr
tr
doppler
studi
number
diseas
affect
myocardium
cat
briefli
consid
myocarditisnonsuppur
myocard
occur
sporad
cat
caus
unknown
definit
diagnosi
requir
microscop
examin
myocardium
sinc
myocardi
biopsi
difficult
cat
enzym
plasma
troponini
elev
nonspecif
inflamm
diagnosi
usual
tent
reserv
necropsi
tabl
cat
myocard
present
ventricular
arrhythmia
other
develop
fulmin
heart
failur
rcm
chronic
myocard
heal
phase
thromboembol
right
ventricular
cardiomyopathya
cardiomyopathi
involv
rv
report
cat
clinic
find
explain
rightsid
myocardi
failur
sever
right
ventricular
cardiac
dilat
may
atrial
standstil
appar
atrial
fibril
murmur
tricuspid
regurgit
may
evid
ventricular
ectop
rhythm
common
pleural
effus
ascit
develop
chf
sudden
death
may
occur
diagnosi
depend
echocardiographi
exclus
predomin
rightsid
diseas
atrial
septal
defect
tricuspid
valv
malform
pulmonari
hypertens
hyperthyroidismclin
find
hyperthyroid
heart
diseas
common
older
cat
function
thyroid
tumor
thyrotoxicosi
caus
cardiac
hypertrophi
relat
hypermetabol
state
peripher
vasodil
increas
demand
cardiac
output
addit
increas
sympathet
activ
elev
thyroid
hormon
concentr
may
stimul
myocardi
hypertrophi
lv
hypertrophi
usual
decreas
except
cat
concurr
diseas
uncontrol
hypertens
primari
idiopath
hcm
hypertens
may
improv
resolv
cardiac
output
decreas
reduct
thyroid
concentr
howev
caus
hypertens
may
endur
especi
primari
renal
diseas
requir
medic
manag
amlodipin
sinu
tachycardia
prematur
beat
usual
resolv
initi
antithyroid
medic
methimazol
tapazol
persist
tachycardia
may
indic
concurr
chf
need
lowdos
betablock
atenolol
tablet
po
twice
daili
small
percentag
cat
cardiac
effect
hyperthyroid
manifest
clinic
signific
manner
thorac
radiograph
demonstr
heart
moder
sever
enlarg
care
scrutini
may
indic
small
even
larg
pleural
effus
patient
full
cardiac
workup
indic
reexamin
patient
may
indic
promin
jugular
puls
overt
jugular
venou
distens
compat
plasma
volum
expans
heart
diseas
advanc
hyperthyroid
suffici
cardiac
dysfunct
volum
expans
caus
gener
cardiomegali
echocardiographi
often
show
biatrial
dilat
normal
even
reduc
lv
shorten
fraction
despit
thicken
lv
wall
measur
affect
cat
evalu
concurr
hypertens
anemia
renal
failur
great
care
must
taken
administ
fluid
therapi
larg
pleural
effus
may
occur
thoracocentesi
may
need
cat
advanc
cardiac
diseas
antithyroid
medic
initi
without
delay
betablock
avoid
prevent
cardiac
depress
acei
prescrib
cardiac
protect
control
incipi
overt
chf
antihypertens
effect
therapi
hyperthyroid
heart
diseas
predic
control
underli
disord
discuss
chapter
treatment
chf
complic
hyperthyroid
discuss
system
hypertensioncat
system
hypertens
may
develop
progress
lv
diseas
concentr
ventricular
hypertrophi
left
ventricl
small
coronari
arteri
repres
one
target
organ
high
blood
pressur
healthi
cat
systol
abp
measur
mm
hg
hospit
set
persist
elev
abp
particularli
valu
exceed
mm
hg
presenc
target
organ
injuri
highli
suggest
hypertens
diseas
system
hypertens
increas
lv
workload
stimul
myocardi
hypertrophi
heart
failur
common
complic
diseas
unless
hypertens
progress
uncheck
superimpos
anoth
form
heart
diseas
initi
clinic
sign
often
refer
target
organ
name
eye
retin
hemorrhag
detach
brain
depress
abnorm
behavior
stroke
kidney
progress
azotemia
dissect
aorta
rare
vascular
complic
hypertens
cardiac
chang
hypertens
often
resembl
mild
hcm
often
gallop
sound
murmur
uncertain
origin
along
mild
cardiac
enlarg
evid
radiographi
echocardiographi
mani
cat
older
may
degen
chang
aorta
observ
aortoannular
ectasia
dilat
aortic
redund
diagnosi
hypertens
usual
straightforward
discuss
detail
chapter
section
assess
hypertens
complic
exampl
hypertens
hyperthyroid
cat
may
relat
high
cardiac
output
lv
hypertrophi
sympatheticallydriven
heart
increas
aortic
imped
stiff
relat
concurr
aortoannular
ectasia
abnorm
plasma
volum
reninangiotensin
regul
concurr
often
mask
renal
diseas
caus
system
hypertens
includ
intrins
renal
diseas
hyperthyroid
conn
syndrom
sought
lv
hypertrophi
may
regress
follow
success
control
blood
pressur
treatment
system
hypertens
cat
discuss
fulli
chapter
acut
arteri
thromboembol
commonli
associ
cardiomyopathi
though
may
encount
multisystem
disord
includ
hematolog
diseas
endocard
cancer
thrombi
gener
aris
laauricl
mani
larg
travers
aortic
arch
lodg
termin
aorta
creat
classic
saddl
thrombu
origin
extern
iliac
arteri
saddl
thrombu
also
obstruct
intern
iliac
branch
serv
tail
obstruct
flow
femor
arteri
extend
directli
extern
iliac
system
smaller
clot
may
divert
vascular
bed
caus
myocardi
infarct
arrhythmia
sudden
death
acut
chf
thrombot
stroke
forelimb
monoparesi
renal
infarct
rare
mesenter
ischemia
sever
colic
pathogenesi
atrial
thrombu
format
like
relat
atrial
dilat
stagnant
blood
flow
reduc
atrial
contractil
exposur
platelet
subendocardi
collagen
illdefin
hemostat
factor
particular
cat
impair
collater
blood
flow
believ
pivot
genesi
clinic
sign
ate
sinc
simpl
ligat
femor
arteri
reproduc
syndrom
cat
histor
sign
ate
typic
includ
sudden
inabl
walk
use
forelimb
sever
pain
vocal
obviou
distress
rapid
deep
breath
pattern
physic
examin
usual
reveal
distress
nonambulatori
patient
often
assum
sit
posit
extend
firm
pain
rear
limb
respiratori
rate
increas
either
pain
concurr
chf
radiographi
often
need
delin
basi
dyspnea
manag
chf
need
cat
see
result
cardiac
auscult
depend
part
experi
examin
often
murmur
gallop
sound
detect
cat
heart
sound
remark
normal
shocklik
sign
evid
cat
probabl
relat
system
reaction
releas
mediat
thrombu
abp
must
measur
forelimb
bradycardia
like
associ
hypotens
requir
addit
treatment
dobutamin
laboratori
test
variabl
probabl
relat
part
underli
diseas
stressrel
hyperglycemia
typic
varieti
electrolyt
abnorm
may
seen
diagnosi
aortoiliac
ate
straightforward
base
usual
histori
result
physic
examin
demonstr
triad
peripher
vascular
diseas
muscl
injuri
peripher
neuropathi
loss
region
vascular
suppli
lead
cold
pulseless
pale
limb
doppler
flow
signal
within
proxim
femor
arteri
system
absent
indic
flow
reduc
collater
blood
flow
superfici
rectal
temperatur
often
reduc
thermomet
lubric
care
advanc
obtain
repres
bodi
temperatur
sever
skelet
muscl
injuri
extens
rhabdomyolysi
occur
lead
ischem
contractur
sever
muscl
pain
well
releas
high
level
ck
ast
alt
damag
muscl
blood
limb
typic
firm
palpat
especi
semitendinosu
gastrocnemiu
muscl
sinc
muscl
contain
high
concentr
potassium
also
leak
cell
may
profound
hyperkalemia
follow
reperfus
damag
tissu
cat
develop
antibioticrespons
fever
within
day
thrombot
event
treat
affect
cat
empir
amoxicillin
trihydr
potassium
clavulan
clavamox
day
develop
limb
edema
indic
sever
tissu
injuri
portend
poor
prognosi
limb
recoveri
case
tissu
necrosi
limb
contractur
may
requir
wound
manag
even
limb
amput
peripher
ischem
neuropathi
identifi
motor
function
absent
rear
limb
forelimb
case
brachial
thrombu
tail
movement
lost
typic
saddl
thrombu
neurolog
sign
usual
bilater
may
asymmetri
note
limb
often
correl
presenc
return
puls
leastaffect
side
hour
rel
clear
superfici
sensori
level
detect
proxim
limb
time
descend
toward
toe
revascular
tail
function
return
first
motor
function
restor
proxim
distal
residu
distal
propriocept
deficit
common
prevent
function
limb
use
recoveri
thrombu
common
hour
mani
cat
alreadi
begun
revascular
limb
spontan
mortal
first
hour
gener
due
one
three
factor
euthanasia
reperfus
hyperkalemia
uncontrol
chf
usual
present
time
admiss
studi
report
worstcas
scenario
recoveri
releas
rate
cat
euthanat
without
treatment
given
suffici
time
recoveri
includ
obvious
client
veterinarian
percept
expect
weigh
heavili
figur
euthanat
cat
consid
least
cat
report
releas
hospit
retrospect
studi
recent
survey
includ
largest
minnesota
studi
demonstr
releas
rate
cat
support
manag
aggress
diseas
concurr
chf
worsen
prognosi
retrospect
studi
smith
colleagu
differ
median
surviv
cat
releas
hospit
day
chf
cat
compar
day
without
chf
despit
potenti
shortterm
success
complic
ate
creat
difficult
decis
client
risk
futur
ate
high
probabl
exceed
within
month
howev
subsequ
embol
event
often
better
toler
presum
relat
develop
collater
circul
client
also
must
advis
regard
sever
underli
heart
diseas
evalu
radiographi
echocardiographi
ecg
manag
ate
discuss
number
cv
drug
use
manag
myocardi
felin
cv
disord
wellconduct
studi
antihypertens
therapi
cat
littl
way
control
suffici
power
clinic
studi
address
treatment
asymptomat
hcm
therapi
heart
failur
manag
ate
cat
primari
cardiomyopathi
accordingli
treatment
approach
myocardi
diseas
remain
larg
empir
certainli
guid
experi
clinic
prejudic
major
therapeut
endpoint
deal
surviv
client
observ
symptom
need
hospit
relat
clinic
sign
diseas
theoret
base
treatment
rational
mani
current
recommend
therapi
consid
drug
effect
left
ventricular
function
diastol
fill
dynam
obstruct
systol
protect
myocardium
stress
catecholamin
neurohormon
prevent
control
chf
prevent
treatment
ate
prevent
arrhythmia
sudden
cardiac
death
clinic
pharmacolog
specif
drug
use
treatment
chf
cat
detail
cardiovascular
drug
elsewher
section
manag
system
hypertens
cat
discuss
detail
chapter
practic
asymptomat
hcm
common
form
idiopath
cardiomyopathi
identifi
cat
main
benefit
therapi
group
would
relat
improv
ventricular
diastol
function
reduct
dynam
outflow
tract
gradient
decreas
mr
reduc
chanc
sudden
cardiac
death
prevent
ate
regress
lvh
current
data
indic
substanti
benefit
therapi
asymptomat
cat
hcm
well
known
mani
cat
live
year
without
appar
problem
increasingli
cat
asymptomat
mild
hcm
normal
la
size
left
untreat
mani
cat
show
littl
progress
diseas
follow
thu
asymptomat
cat
veterinarian
could
reason
consid
prescrib
therapi
empir
badrenerg
blocker
diltiazem
client
indic
cat
activ
receiv
treatment
may
simpli
repres
placebo
effect
initi
cat
asymptomat
diseas
examin
repeat
echocardiographi
within
month
initi
stabl
therapi
regimen
month
later
depend
level
concern
impend
chf
ate
echocardiographi
advantag
provid
object
measur
wall
thick
la
size
doppler
studi
use
document
reduct
dynam
obstruct
associ
mr
flow
disturb
identifi
initi
examin
stabl
cat
seen
everi
month
interv
extend
follow
examin
show
diseas
progress
mani
case
diseas
unchang
other
clear
progress
eventu
sign
chf
ate
occur
even
year
initi
diagnosi
therapi
atenololbblock
recommend
manag
hcm
moder
sever
lv
outflow
tract
obstruct
atenolol
often
prescrib
purpos
twice
daili
drug
compar
tid
propranolol
usual
start
dose
atenolol
tablet
po
day
thereaft
tablet
po
dosag
adjust
achiev
examin
heart
rate
typic
cat
receiv
tablet
either
tablet
pm
atenolol
effect
reduc
lvot
gradient
consist
slow
heart
time
stress
exampl
veterinari
examin
cardiac
benefit
betablock
cat
hcm
includ
prevent
sinu
tachycardia
reduc
dynam
outflow
obstruct
decreas
sam
attend
mitral
regurgit
prolong
diastol
myocardi
oxygen
demand
reduc
decreas
heart
rate
contractil
blood
pressur
unfortun
net
effect
betablockad
diastol
function
cat
hcm
unknown
see
cardiovascular
drug
discuss
betablockad
especi
help
reduc
pressur
gradient
caus
dynam
lv
outflow
obstruct
cat
hcm
murmur
mitral
regurgit
gener
becom
softer
follow
betablockad
peak
outflow
tract
veloc
substanti
reduc
major
cat
given
adequ
dose
atenolol
small
european
studi
anoth
betablock
propranolol
associ
regress
lv
hypertrophi
find
inconsist
expect
betablock
contraind
cat
overt
hypotens
bradycardia
uncontrol
pulmonari
edema
av
block
recent
arteri
thromboembol
collater
circul
restor
furthermor
valu
cat
recentonset
chf
appear
unfavor
base
recent
multicent
studi
routin
prescrib
shortterm
manag
chf
patient
therapi
diltiazemwhen
hcm
character
moder
sever
lv
hypertrophi
without
obstruct
especi
concurr
la
dilat
diltiazem
may
therapeut
consider
dose
typic
involv
longact
prepar
standard
diltiazem
dose
tablet
po
simpli
impract
cat
owner
dilacor
xr
brand
diltiazem
administ
dosag
mg
twice
daili
open
mg
capsul
cut
four
pill
half
other
use
longact
diltiazem
capsul
cardizem
cd
compound
palat
syrup
start
mg
diltiazem
daili
bioavail
dose
regimen
prepar
issu
diltiazem
thought
improv
lv
relax
precis
mechan
benefit
elucid
see
cardiovascular
drug
discuss
overal
diltiazem
reduc
myocardi
oxygen
demand
decreas
contractil
blood
pressur
heart
rate
though
less
effect
atenolol
diltiazem
neg
inotrop
effect
reduc
dynam
outflow
tract
gradient
somewhat
disappoint
dose
commonli
use
chronic
administr
diltiazem
report
decreas
lv
hypertrophi
cat
sever
hcm
uncommon
observ
regress
even
prolong
therapi
thu
main
reason
choos
diltiazem
therapi
cat
hcm
potenti
improv
diastol
function
prevent
treatment
chf
hcm
contraind
administr
diltiazem
cat
uncontrol
chf
sinu
bradycardia
hypotens
av
block
bradycardia
hypotens
depress
skin
reaction
erythemaedema
observ
cat
receiv
drug
anorexia
rel
common
client
complaint
advers
effect
report
cat
one
clinic
report
atenolol
diltiazem
appear
role
shortterm
manag
chf
cat
acei
therapyth
potenti
angiotensin
convert
enzym
inhibitor
acei
benefit
hcm
demonstr
thu
far
except
cat
overt
chf
theoret
acei
especi
tissuesensit
acei
ramipril
could
prevent
progress
myocardi
injuri
fibrosi
asymptomat
hcm
howev
firm
evid
benefit
author
recommend
reserv
acei
case
document
chf
moder
sever
la
dilat
document
echocardiographi
especi
set
doppler
evid
elev
la
pressur
treatment
acut
heart
failur
cat
challeng
may
requir
aggress
initi
treatment
effort
direct
improv
tissu
hypoxia
reliev
stress
reduc
venou
pulmonari
capillari
pressur
mani
cat
manag
medic
use
fon
approach
furosemideoxygennitroglycerinesed
thoracocentesi
perform
moder
larg
pleural
effus
intub
hour
artifici
ventil
may
need
manag
impend
respiratori
arrest
cat
expector
edema
fluid
initi
dosag
furosemid
typic
mgkg
ivim
follow
mgkg
bolus
iv
im
everi
hour
cat
stabl
cat
place
rest
administ
oxygen
cage
oxygen
sedat
case
reliev
anxieti
butorphanol
mg
kg
mix
acepromazin
mgkg
cocktail
administ
subcutan
rectal
temperatur
set
bradycardia
avoid
acepromazin
nitroglycerin
ointment
also
administ
dose
inch
moder
sever
pulmonari
edema
iv
establish
without
stress
constant
rate
infus
furosemid
substitut
repeat
bolus
calcul
daili
dose
infus
continu
hour
treatment
continu
hour
cri
lasix
supplement
addit
iv
bolus
need
cat
cardiogen
shock
hypothermia
bradycardia
systol
abp
mm
hg
treat
iv
dobutamin
infus
mcgkgmin
titrat
abp
mm
hg
hour
effect
therapi
cardiogen
shock
regardless
underli
form
cardiomyopathi
cat
diures
ventil
stabl
oxygen
withdrawn
nitrat
ointment
discontinu
dosag
furosemid
reduc
ultim
dose
furosemid
titrat
sever
pulmonari
edema
pleural
effus
mani
cat
develop
hypokalemia
preren
azotemia
intens
diuret
therapi
fresh
water
palat
food
avail
shortli
diuresi
initi
mild
case
renal
failur
need
treat
cat
refus
eat
drink
hour
therapi
judici
fluid
therapi
balanc
solut
eg
mlkgday
combin
potassium
supplement
iv
oral
need
liquid
nutrit
support
given
indwel
nasogastr
tube
may
consid
anorexia
persist
hour
howev
cat
begin
eat
follow
effect
resolut
chf
therapi
chronic
chf
cat
cardiomyopathi
base
two
drug
furosemid
mgkg
po
twice
daili
acei
enalapril
benazepril
mgkg
po
twice
daili
uptitr
dose
number
week
spironolacton
mg
tablet
daili
given
empir
cardioprotect
potassiumspar
effect
sinc
cat
also
la
dilat
treatment
prevent
thromboembol
usual
consid
see
howev
aspirin
therapi
combin
acei
diuret
may
predispos
renal
failur
aspirin
prescrib
purpos
ultralow
dose
mg
per
cat
may
safer
altern
gener
neither
atenolol
diltiazem
administ
cat
overt
chf
therapi
shown
either
detriment
benefici
shortterm
outcom
least
month
stabl
chf
control
atenolol
consid
cat
sever
lvot
obstruct
begin
tablet
daili
cautious
uptitr
dosag
sever
week
reliev
obstruct
excess
dose
may
worsen
chf
lead
pleural
effus
recurr
pulmonari
edema
benefit
diltiazem
cat
chf
hcm
proven
might
consid
cat
stabl
furosemid
acei
spironolacton
cat
dilat
cardiomyopathi
evalu
taurin
defici
particularli
atrisk
breed
includ
burmes
abyssinian
siames
treat
taurin
mg
twice
daili
week
pend
result
wholeblood
taurin
analysi
bioflavonoid
rutin
mg
prescrib
evid
recurr
pleural
effus
chylothorax
rutin
improv
macrophag
function
may
reduc
reactiv
pleuriti
decreas
accumul
chylomicron
within
pleural
space
clinic
trial
inodil
pimobendan
underway
cat
may
provid
addit
treatment
cat
chronic
chf
overal
efficaci
heart
failur
therapi
gaug
monitor
respiratori
rate
depth
home
regular
reexamin
consider
affect
cat
activ
level
appetit
interact
famili
member
offer
reason
gaug
qualiti
life
object
measur
chf
control
obtain
care
physic
cardiovascular
examin
inspect
serial
thorac
radiograph
morpholog
function
progress
heart
diseas
assess
echocardiographi
desir
clinic
reevalu
includ
client
interview
physic
examin
abp
measur
serum
biochem
profil
thorac
radiograph
even
one
later
view
provid
object
evid
regard
fluid
retent
focus
recheck
echocardiogram
time
specif
examin
depend
clinic
circumst
econom
consider
initi
occur
within
first
day
initi
diagnosi
chf
continu
everi
one
two
week
chf
control
renal
function
stabl
thereaft
interv
may
extend
everi
one
three
month
depend
patient
progress
gener
progress
azotemia
indic
effect
diuret
plu
acei
possibl
dose
reduc
cat
heart
may
stabil
allow
drug
diuret
therapi
ceas
case
clear
need
simpli
toler
azotemia
prevent
pleural
effus
pulmonari
edema
treatment
ventricular
tachycardia
vt
cat
chf
problemat
propranolol
mg
po
atenolol
mg
po
twice
daili
procainamid
capsul
compound
mix
food
use
sotalol
use
cat
hard
dose
research
studi
effect
mainli
betablock
dosag
neg
inotrop
effect
mention
drug
poor
client
patient
complianc
lack
efficaci
studi
limit
applic
treatment
gener
therapi
vt
reserv
symptomat
ie
syncop
patient
danger
ventricular
arrhythmia
document
ecg
diltiazem
effect
blocker
av
nodal
conduct
repres
excel
choic
heart
rate
control
cat
atrial
fibril
longterm
prognosi
chf
cat
guard
quit
variabl
although
report
indic
surviv
time
six
month
less
surviv
uncommon
follow
onset
heart
failur
provid
client
medic
cat
home
will
obtain
consist
veterinari
care
cat
success
manag
chf
year
remark
cat
chf
wean
medic
reason
unknown
wherea
other
relentless
downhil
cours
requir
higher
higher
dose
diuret
regular
thoracocentesi
progress
chf
refractori
pleural
effus
ate
present
formid
obstacl
longterm
surviv
cat
manag
thromboembol
complic
felin
cardiomyopathi
remain
seriou
challeng
beyond
anticip
spontan
revascular
limb
suffici
time
elaps
establish
medic
surgic
intervent
cathet
treatment
avail
resolv
acut
ate
cat
unfortun
prospect
studi
demonstr
efficaci
prevent
treatment
acut
thromboembol
eventtreat
requir
highqual
critic
care
good
nurs
tinctur
time
remain
propens
euthan
cat
ate
within
veterinari
commun
though
publish
data
suggest
least
chanc
good
function
recoveri
median
surviv
time
month
cat
without
chf
prognosi
discuss
previous
chapter
client
request
care
suffici
time
least
day
allow
improv
case
day
hospit
stay
need
cat
show
improv
within
hour
conserv
therapi
pain
markedli
diminish
within
hour
event
key
point
manag
pain
main
therapeut
concern
first
hour
treatment
cat
arteri
thromboembol
initi
treatment
cat
ate
involv
analgesia
opioid
abp
normal
acepromazin
mgkg
ad
sedat
patient
opioid
use
cat
includ
butorphanolthi
drug
agonist
antagonist
mu
receptor
dose
mgkg
imsq
drug
readili
avail
veterinari
practic
rel
weak
analges
magnitud
pain
butorphanol
consid
stepdown
analges
therapi
potenti
revers
effect
mu
agonist
buprenorphin
buprenix
dose
mgkg
im
sq
buprenorphin
longer
act
partial
mu
agonist
better
altern
butorphanol
hydromorphon
morphinethes
opiat
full
mu
agonist
use
cat
mg
kg
im
bewar
respiratori
depress
cn
excit
hyperthermia
possibl
combin
acepromazin
fentanylfentanyl
potent
mu
agonist
infus
mcgkg
initi
slow
iv
bolu
maintain
mcgkghour
also
combin
acepromazin
opiat
acepromazin
combin
provid
effect
analgesiased
mani
cat
moder
distress
epidur
anesthesia
effect
control
rear
limb
pain
cat
ate
inject
requir
expertis
local
analgesia
may
increas
risk
epidur
hemorrhag
cat
receiv
anticoagul
therapi
sodium
bicarbon
meqkg
iv
minut
sometim
administ
cat
shock
document
evid
metabol
acidosi
andor
hyperkalemia
muscl
necrosi
reperfus
control
bodi
temperaturemani
cat
ate
hypotherm
especi
concurr
chf
warm
prefer
oxygen
enrich
environ
suppli
import
avoid
overh
cat
ate
damag
limb
dissip
heat
normal
may
burn
opiat
use
analgesia
may
impact
thermoregulatori
center
sometim
cat
opiat
pant
abat
extern
environment
temperatur
lower
heat
blanket
remov
dose
acepromazin
administ
elev
temperatur
persist
true
fever
may
evid
altern
caus
ate
consid
includ
bacteri
endocard
dissemin
neoplasia
howev
case
fever
relat
ate
usual
respond
iv
cefazolin
oral
clavamox
heparin
administ
ate
prevent
thrombosi
initi
dose
ukg
intraven
subcutan
ukg
everi
hour
hour
clinician
also
administ
one
babi
aspirin
mg
cat
present
within
hour
ate
event
betablock
especi
propranolol
avoid
cat
walk
without
difficulti
chf
issu
iv
cathet
place
forelimb
mainten
fluid
therapi
administ
maintain
urinari
output
reduc
hyperkalemia
follow
reperfus
excit
wane
iv
streptokinas
iu
iv
min
follow
iuhour
hour
streptokinas
longer
avail
excit
wane
iv
tissu
plasminogen
activ
mgkghour
total
dose
mgkg
expens
treatment
difficult
control
carri
high
mortal
rate
probabl
relat
reperfus
hyperkalemia
clinician
must
appreci
limb
reperfusionwheth
spontan
induc
thrombolyt
drugcan
lead
fatal
hyperkalemia
rapid
reperfus
necrot
muscl
cat
releas
hospit
day
provid
evid
revascular
femor
puls
improv
motor
function
tail
proxim
limb
client
counsel
regard
home
care
includ
protect
limb
trauma
burn
daili
inspect
edema
maintain
written
log
progress
rel
limb
function
ambul
provid
low
stress
environ
comfort
bed
area
cat
convalesc
like
bed
soil
urin
stool
may
help
use
easili
washabl
fabric
appli
appropri
protect
bed
offer
highli
palat
food
fresh
water
readili
avail
near
bed
supplement
handfeed
encourag
eat
drink
place
litter
pan
rel
near
bed
assist
cat
use
litter
pan
necessari
constip
becom
problem
small
amount
solubl
fiber
teaspoon
guar
gum
benefib
can
pumpkin
mix
food
may
soften
stool
administ
prescrib
medic
chf
administ
drug
prevent
thrombot
episod
see
follow
prevent
atedrug
prevent
thromboemboli
recommend
atrial
enlarg
mm
echo
prior
histori
ate
aggress
treatment
usual
proport
risk
high
risk
cat
includ
follow
find
prior
document
thromboembol
establish
thrombu
la
appendag
evid
spontan
la
echocardiograph
contrast
la
dimens
exceed
mm
especi
loss
activ
auricular
contract
measur
pw
doppler
echocardiographi
atrial
fibril
three
empir
approach
prevent
develop
aspirin
interfer
platelet
function
mg
coat
buffer
aspirin
given
everi
third
day
ultralow
dose
aspirin
given
mg
per
cat
everi
hour
easiest
administ
prevent
disadvantag
rel
poor
efficaci
daili
warfarin
inhibit
vitamink
depend
clot
factor
start
tablet
daili
approach
creat
practic
problem
term
dose
monitor
creat
risk
iatrogen
hemorrhag
low
molecular
weight
heparin
subcutan
inject
twice
daili
inhibit
thrombogenesi
dalteparin
enoxaparin
dose
ukg
sq
use
though
oncedaili
dose
dalteparin
also
might
success
empir
success
drug
expens
requir
inject
limit
widespread
use
specif
approach
well
addit
detail
prevent
thromboembol
discuss
fulli
chapter
along
newer
treatment
approach
clopidogrel
bisulf
plavix
tablet
daili
myocardi
diseas
common
caus
heart
failur
arrhythmia
cardiovascular
mortal
dog
follow
chronic
valvular
heart
diseas
preval
clinic
import
recogn
form
cardiomyopathi
dog
includ
follow
condit
dilat
cardiomyopathi
dcm
common
canin
myocardi
diseas
idiopath
genet
dilat
cardiomyopathi
dcm
character
decreas
left
ventricular
eject
fraction
cardiac
remodel
lv
dilat
congest
heart
failur
arrhythmiasboth
atrial
ventricularar
common
phase
diseas
sudden
cardiac
death
rel
common
affect
breed
arrhythmogen
right
ventricular
cardiomyopathi
arvc
asid
dcm
often
recogn
form
cardiomyopathi
arrhythmogen
right
ventricular
cardiomyopathi
arvc
best
character
boxer
dog
associ
ventricular
ectopi
syncop
heart
failur
sudden
cardiac
death
less
common
variant
diseas
right
ventricular
dysplasia
character
sever
replac
myocardium
connect
tissu
progress
rightsid
chf
persist
atrial
standstil
disord
caus
replac
atrial
myocardium
fibrou
connect
tissu
consequ
chronic
bradycardia
rightsid
chf
mainli
affect
springer
spaniel
idiopath
hypertroph
cardiomyopathi
hcm
condit
true
hcm
rare
dog
includ
differenti
diagnosi
leftsid
chf
sudden
death
hypertroph
cardiomyopathi
must
distinguish
congenit
subaort
stenosi
mitral
malform
caus
dynam
subvalvular
aortic
stenosi
hypertens
heart
diseas
secondari
hypertrophi
diseas
caus
iatrogen
thyrotoxicosi
secondari
cardiomyopathiescaus
canin
myocardi
diseas
includ
profound
hypothyroid
iatrogen
hyperthyroid
doxorubicin
adriamycin
administr
catecholamin
injuri
includ
pheochromocytoma
head
trauma
brainheart
syndrom
system
carnitin
defici
sever
taurin
defici
protract
myocardi
ischemia
duchenn
myopathi
cardiomyopathi
overload
chronic
volum
pressur
overload
caus
congenit
shunt
valvular
diseas
hypertens
progress
cardiomyopathi
overload
wherein
ventricl
hypertrophi
systol
myocardi
function
impair
tachycardiainduc
cardiomyopathi
relentless
supraventricular
ventricular
tachycardia
caus
revers
myocardi
failur
herd
malign
ventricular
tachycardia
young
german
shepherd
describ
detail
mois
colleagu
myocard
cardiac
inflamm
dog
due
chaga
diseas
endem
area
septicemia
lyme
diseas
newborn
puppi
parvoviru
dilat
cardiomyopathi
idiopath
genet
famili
myocardi
diseas
character
left
ventricular
biventricular
dilat
reduc
myocardi
contractil
histolog
abnorm
within
ventricl
necropsi
studi
echocardiographi
often
demonstr
fourchamb
dilat
profound
enlarg
left
ventricl
left
atrium
chf
often
identifi
canin
patient
postmortem
examin
microscop
lesion
includ
absenc
inflamm
attenu
wavi
fiber
fibrofatti
replac
myocyt
interstiti
fibrosi
alter
cytoskelet
matrix
extramur
coronari
arteri
normal
valv
unremark
except
older
dog
concurr
mitral
tricuspid
valv
endocardiosi
diseas
dog
believ
famili
doberman
pinscher
probabl
domin
trait
timecours
progress
dcm
reportedli
great
howev
patient
clearli
develop
lv
dysfunct
within
short
time
interv
defici
myocardi
metabol
substrat
lcarnitin
taurin
identifi
small
percentag
affect
dog
often
relat
famili
diseas
gross
dietari
defici
supplement
micronutri
nutriceut
coenzym
q
may
benefici
energet
fail
cardiac
muscl
treatment
revers
canin
dcm
except
rare
case
system
substrat
deplet
systol
dysfunct
progress
limit
cardiac
output
compens
activ
neurohormon
cytokin
releas
support
arteri
blood
pressur
neurohormon
assault
caus
myocardi
damag
left
ventricular
eject
fraction
continu
decreas
heart
dilat
ventricular
diastol
dysfunct
recogn
detail
echocardiograph
studi
secondari
atrioventricular
valvular
regurgit
often
develop
lead
murmur
mitral
tricuspid
regurgit
exercis
capac
reduc
earli
sign
heart
failur
arteri
underfil
promot
renal
sodium
retent
expand
plasma
volum
combin
reduc
left
ventricular
perform
venou
pressur
increas
chf
ensu
arrhythmia
occur
time
cours
dcm
syncop
sudden
cardiac
death
onset
chf
potenti
consequ
rhythm
disturb
sudden
death
especi
common
doberman
pinscher
dcm
frequent
biventricular
chf
precipit
develop
af
dog
previous
compens
dcm
see
figur
dilat
cardiomyopathi
occur
often
middleag
older
larg
giant
breed
dog
doberman
pinscher
great
dane
irish
wolfhound
newfoundland
boxer
dcm
affect
dog
age
mani
breed
often
male
dog
predispos
like
affect
young
age
breed
risk
older
dog
often
tend
femal
addit
high
preval
larger
breed
dcm
recogn
regularli
varieti
spaniel
retriev
breed
dalmatian
portugues
water
dog
dcm
occur
sporad
small
canin
breed
genet
famili
basi
dcm
obviou
mani
breed
specif
mutat
allel
respons
yet
demonstr
four
common
clinic
present
dcm
occult
dcm
chf
cardiac
arrhythmia
sudden
cardiac
death
first
three
condit
review
reader
also
direct
chapter
heart
failur
dog
detail
descript
treatment
plan
canin
heart
failur
cardiovascular
drug
discuss
clinic
pharmacolog
use
drug
heart
failur
arrhythmia
cardiac
rhythm
disturb
review
electrocardiograph
featur
arrhythmia
occult
dcm
refer
overtli
healthi
dog
evid
systol
dysfunct
echocardiographi
also
consid
diagnosi
occult
dcm
viabl
breedatrisk
dcm
doberman
pinscher
irish
wolfhound
develop
persist
recurr
atrial
ventricular
arrhythmia
attribut
anoth
recogn
caus
regard
crossov
reason
debat
design
occult
dcm
arrhythmia
normal
echocardiogram
arrhythmogen
cardiomyopathi
principl
disturb
electr
echocardiogram
normal
see
myocardi
dysfunct
certainli
develop
mani
dog
persist
cardiac
arrhythmia
littl
doubt
mani
dog
dcm
spend
time
arrhythmogen
cardiomyopathi
progress
typic
dilat
form
purpos
discuss
classifi
dog
persist
arrhythmia
normal
echocardiogram
arrhythmogen
cardiomyopathi
lv
dysfunctionwith
without
arrhythmiasa
occult
dcm
distinct
may
seem
academ
clear
trend
use
cardioprotect
drug
betablock
acei
dog
occult
dcm
thu
one
perspect
requir
demonstr
systol
dysfunct
label
patient
occult
dcm
may
influenc
whether
earli
intervent
prescrib
diagnos
occult
dcm
made
breeder
request
cardiologist
screen
import
dog
follow
veterinari
examin
uncov
murmur
arrhythmia
tion
minor
axi
estim
lv
systol
function
shorten
fraction
diagnost
criterion
lv
shorten
fraction
lv
diastol
dimens
minu
lv
systol
dimens
divid
lv
diastol
dimens
valu
consid
suspici
occult
dcm
unanim
one
specif
figur
indic
myocardi
failur
healthi
dog
live
mani
year
shorten
fraction
singl
linear
approach
diagnosi
also
question
larger
dog
shorten
rel
apic
basilar
direct
motion
assess
shorten
fraction
howev
data
doberman
pinscher
indic
specif
ventricular
measur
enddiastol
dimens
mm
endsystol
dimens
mm
highli
predict
dcm
accept
diagnosi
occult
dcm
clinician
request
detail
echocardiograph
measur
systol
function
includ
lv
shortaxi
shorten
area
normal
apicaltobasilar
mitral
annular
motion
volumetr
estim
lv
eject
fraction
normal
singl
plane
model
advanc
doppler
method
assess
also
avail
requir
definit
serial
echocardiograph
examin
help
establish
downward
trend
lv
function
one
accept
howev
daytoday
variat
uncommon
measur
calcul
echocardiograph
variabl
larg
differ
trend
meaning
tini
movement
holter
ecgth
ambulatori
ecg
use
adjunct
diagnosi
occult
dcm
arrhythmogen
cardiomyopathi
holter
record
may
help
establish
diagnosi
breed
highli
prone
dcm
cardiac
arrhythmia
doberman
pinscher
cardiologist
consid
vpc
per
day
clearli
abnorm
consid
even
lower
number
vpc
abnorm
dog
ventricular
ectopi
evid
auscult
routin
ecg
holter
record
provid
object
inform
sever
rhythm
disturb
diagnosticsfutur
direct
like
lead
depend
biomark
troponin
natriuret
peptid
identif
myocardi
diseas
breed
risk
screen
echocardiogram
return
ambigu
result
breeder
alway
hope
test
provid
earliest
recognit
diseas
unrealist
expect
phenotyp
test
matter
sophist
identifi
genet
affect
anim
within
breed
line
mani
dog
develop
dcm
demonstr
sign
later
year
long
breed
ceas
regard
genet
test
better
answer
particular
group
client
dog
manag
occult
dcm
involv
protect
myocardium
manag
seriou
arrhythmia
acei
prescrib
dog
document
occult
dcm
base
echocardiographi
enalapril
benazepril
mgkg
po
twice
daili
appropri
lv
function
poor
bid
dose
attain
time
report
ogradi
colleagu
doberman
pinscher
treatment
enalapril
roughli
doubl
time
durat
diagnosi
occult
dcm
onset
overt
sign
heart
failur
betablockad
carvedilol
metoprolol
also
cardioprotect
consid
dog
occult
dcm
larg
breed
dog
longact
metoprolol
usual
well
toler
tablet
carvedilol
coreg
rel
expens
dog
occult
dcm
like
toler
dog
overt
chf
optim
target
dosag
unknown
initi
dose
mgkg
po
increas
everi
week
target
mgkg
lethargi
exercis
intoler
develop
insur
chf
precipit
blood
pressur
renal
function
test
follow
medic
cardiac
arrhythmia
also
present
holter
ecg
done
assess
arrhythmia
sever
unless
routin
ecg
alreadi
show
sever
antiarrhythm
therapi
consid
discuss
fulli
arrhythmogen
cardiomyopathi
prognosispredict
surviv
occult
dcm
difficult
one
problem
relat
precis
establish
diagnosi
occult
dcm
unambigu
evid
lv
systol
dysfunct
identifi
lvsf
typic
less
dog
sinu
rhythm
normal
ventricular
conduct
develop
chf
like
within
month
even
set
cardioprotect
drug
less
stringent
criteria
set
diagnosi
occult
dcm
mani
dog
still
aliv
year
later
advanc
case
dcm
usual
present
histori
exercis
intoler
clinic
sign
chf
syncop
relat
ventricular
arrhythmia
neural
mediat
syncop
inappropri
bradycardia
vasodil
may
report
owner
physic
examin
reveal
sign
typic
chf
mark
weight
loss
cachexia
arteri
blood
pressur
usual
normal
owe
vasoconstrict
neurohormon
activ
decreas
profound
dcm
cardiogen
shock
auscult
may
reveal
atrial
ventricular
gallop
systol
murmur
arrhythmia
intens
first
heart
sound
strength
arteri
puls
often
diminish
indic
reduc
lv
contractil
stroke
volum
pimobendan
onboard
facilit
uptitr
betablock
unfortun
prescript
drug
coreg
expens
dose
difficult
dog
may
toler
neg
inotropi
bblocker
af
complic
chf
diltiazem
uptitr
mgkg
po
prescrib
control
ventricular
rate
see
detail
next
section
heart
rate
control
longact
form
diltiazem
substitut
use
total
daili
dose
administ
twice
daili
fish
oil
supplement
contain
fatti
acid
may
improv
appetit
reduc
cardiac
cachexia
mgkg
po
daili
mg
kg
po
daili
dog
diagnosi
hypothyroid
ensur
plasma
level
check
prevent
iatrogen
hyperthyroid
condit
increas
demand
cardiac
output
arrhythmogen
gener
even
giant
breed
dog
hypothyroid
receiv
mg
lthyroxin
daili
seriou
ventricular
arrhythmia
set
chf
mexiletin
mgkg
tid
plu
low
dose
betablock
amiodaron
procainamid
altern
result
alway
favor
optim
holter
ecg
use
assess
therapi
term
arrhythmogen
cardiomyopathi
use
express
refer
recurr
persist
ventricular
atrial
arrhythmia
set
normal
echocardiogram
commonli
observ
rhythm
disturb
pvc
ventricular
tachycardia
vt
howev
atrial
rhythm
disturb
may
recogn
includ
atrial
fibril
paroxysm
sustain
atrial
tachycardia
atrial
flutter
discuss
dog
affect
arrhythmogen
cardiomyopathi
clearli
progress
classic
dcm
howev
mani
other
thu
dog
key
clinic
manag
cardiomyopathi
control
cardiac
arrhythmia
arvcarrhythmogen
cardiomyopathi
ventricular
arrhythmia
particularli
common
boxer
dog
also
english
bulldog
term
arrhythmogen
right
ventricular
cardiomyopathi
arvc
use
indic
put
origin
arrhythmia
term
larg
replac
boxer
cardiomyopathi
design
harpster
origin
classif
still
use
mani
boxer
demonstr
isol
pvc
upright
left
bundl
branch
block
morpholog
lead
ii
mani
boxer
carri
type
design
year
without
incid
boxer
often
collaps
faint
due
sustain
vt
classifi
type
ii
boxer
progress
develop
classic
dcm
well
often
mark
biventricular
chf
ventricular
atrial
arrhythmia
common
type
iii
dog
doberman
pinschersth
doberman
pinscher
anoth
breed
often
manifest
ventricular
ectop
prior
develop
overt
myocardi
failur
dcm
mani
dog
die
suddenli
without
premonitori
bout
syncop
onset
heart
failur
other
progress
classic
dcm
leftsid
biventricular
chf
lone
af
irish
wolfhound
great
dane
newfoundland
giant
breed
prone
af
without
obviou
impair
lv
contractil
frequent
onset
af
preced
atrial
prematur
complex
paroxysm
atrial
tachycardia
flutter
consid
anoth
form
arrhythmogen
cardiomyopathi
though
often
design
lone
af
occult
dcm
one
report
averag
time
interv
recognit
af
chf
irish
wolfhound
year
progress
dcm
common
featur
mani
dog
result
report
indic
relationship
af
dcm
less
clear
clinic
assessmenta
data
base
obtain
dog
suspect
arrhythmogen
cardiomyopathi
includ
care
review
clinic
sign
relev
arrhythmia
medic
histori
complet
physic
examin
cbc
serum
biochem
profil
includ
electrolyt
serum
troponini
ctni
routin
ecg
long
rhythm
strip
ambulatori
holter
ecg
especi
rhythm
character
isol
atrial
ventricular
prematur
complex
relat
clinic
sign
holter
ecg
particularli
import
asymptomat
patient
rhythm
strip
indic
clear
need
therapi
echocardiogram
thorac
radiograph
option
inform
clinician
determin
like
etiolog
rhythm
disturb
also
attempt
judg
overal
clinic
signific
arrhythmia
assess
pivot
therapeut
decis
differenti
diagnosisarrhythmogen
cardiomyopathi
must
distinguish
caus
cardiac
arrhythmia
normal
left
ventricular
function
recogn
disord
associ
cardiac
arrhythmia
exclud
exampl
cardiac
tumor
hemangiosarcoma
electrolyt
imbal
hypokalemia
calcium
disturb
system
hypertens
splenic
tumor
postop
traumat
ventricular
arrhythmia
caus
ischemia
reperfus
injuri
drug
histori
obtain
ensur
arrhythmia
caus
drug
hormon
increas
sympathet
tone
includ
excess
supplement
lthyroxin
case
lv
systol
function
reduc
revis
diagnosi
dcm
arrhythmia
appropri
long
tachycardiainduc
cardiomyopathi
elimin
sustain
tachyarrhythmia
caus
revers
tachycardiainduc
dilat
cardiomyopathi
like
tachycardia
relentless
interv
sinu
rhythm
case
valuabl
assess
lv
function
week
control
tachyarrhythmia
rhythm
heart
rate
respons
control
object
assess
ventricular
function
obtain
manag
approach
success
manag
isol
arrhythmia
dog
similar
associ
treatment
arrhythmia
chf
advantag
normal
ventricular
function
allow
wider
select
higher
dosag
antiarrhythm
drug
use
drug
use
control
heart
rhythm
also
depress
cardiac
function
effect
limit
antiarrhythm
drug
use
heart
failur
regard
clinician
vigil
sinc
arrhythmia
may
first
sign
progress
myocardi
diseas
dcm
chf
may
develop
futur
first
question
address
whether
arrhythmia
even
treat
exampl
isol
pvc
atrial
prematur
complex
probabl
treat
potent
antiarrhythm
drug
unless
sign
relat
collaps
syncop
goal
therapi
three
prevent
sudden
death
prevent
reduc
clinic
sign
protect
ventricl
tachycardiainduc
cardiomyopathi
antiarrhythm
therapi
prescrib
discuss
advers
drug
effect
owner
import
follow
ecg
includ
holter
record
discuss
potenti
proarrhythmia
worsen
rhythm
rememb
durat
therapi
depend
like
etiolog
diseas
mani
case
arrhythmogen
cardiomyopathi
treatment
lifelong
client
record
symptom
might
relat
arrhythmia
possibl
advers
effect
drug
follow
patient
regular
interv
begin
client
interview
routin
auscult
follow
standard
ecg
arrhythmia
detect
consid
use
holter
ecg
patient
stabl
routin
ecg
receiv
consist
dose
medic
perform
anoth
holter
ecg
key
point
evalu
respons
therapi
routin
ecg
holter
ecg
lone
atrial
fibril
dog
lone
af
holter
data
provid
insight
daili
heart
rate
exercis
heart
rate
averag
daili
heart
rate
exceed
moderatelevel
exercis
heart
rate
exceed
reason
ground
slow
heart
rate
respons
af
refer
cardiovers
betablock
therapi
heart
rate
controlcontrol
ventricular
rate
respons
achiev
atenolol
mgkg
po
metoprolol
mg
po
twice
daili
giant
breed
drug
also
potenti
cardioprotect
af
premonitori
sign
futur
dcm
first
three
day
initi
dose
betablock
prescrib
dose
prevent
undu
lethargi
thereaft
drug
dose
titrat
week
achiev
appropri
averag
daili
heart
rate
gener
rang
diltiazem
therapi
heart
rate
controlth
use
calcium
channel
blocker
dose
mg
kg
po
effect
control
heart
rate
confer
cardioprotect
betablock
arrhythmia
repres
earli
dcm
initi
dose
mgkg
po
first
day
recommend
increas
dose
diltiazem
use
combin
betablock
longact
prepar
diltiazem
also
use
dose
difficult
use
total
daili
dosag
divid
digoxin
therapywhil
digoxin
prescrib
lone
af
cardiac
glycosid
less
effect
control
excess
exerciserel
rate
recommend
us
evid
heart
failur
cardiovers
convers
af
back
sinu
rhythm
definit
possibl
dog
lone
af
use
procainamid
sotalol
amiodaron
purpos
met
mix
gener
unfavor
result
howev
electr
dc
biphas
cardiovers
highli
success
set
lone
af
especi
giant
breed
provid
lowdos
amiodaron
administ
follow
